Bionor Pharma ASA

Type: Company
Name: Bionor Pharma ASA
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

REG-Mandatory Notification of Trade

Oslo 05.09.2014Reference is made to the stock exchange notice published by Bionor Pharma ASA ("Bionor" or the "Company") published at 07:30 CET today. Bionor announces that members of the Company's Board of Directors and Management participated in the ... [Published Reuters - Sep 05 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

REG-BIONOR PHARMA ASA - CONTEMPLATED PRIVATE PLACEMENT

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATESOslo, 04.09.2014.Bionor Pharma ("Bionor" or the "Company") has engaged Arctic Securities AS and DNB Markets, as part ... [Published Reuters - Sep 04 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Bionor Pharma Q2 net loss decreases

Bionor Pharma ASA, a Norwegian biotechnology company, has reported that net loss for the second quarter ended June 30, 2014 was NOK16.96 million, compared to a net loss of NOK21.33 million for the same quarter ended June 30, 2013.Total revenue for the ... [Published Individual.com - Aug 27 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Bionor Pharma: Vacc-4X Remains On Track

Vacc-4x continues to advance; next data in Q414Bionor Pharma ASA (OSLO:BIONOR) Vacc-4x development remains on track, with ‘Kill & Boost’ data still expected in Q414 and data from the next part of the ongoing Reduc (‘Kill & Kick’) trial anticipated during ... [Published Investing.com - Aug 26 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Worldwide HIV Infection Drug Market Examined in New Kuick Research...

New research report “Global HIV Infection Drug Market & Pipeline Insight” worked out by Kuick Research is now available at MarketPublishers.com. The improved access to antiretroviral drugs and treatments in the recent past, specifically in the developing ... [Published PRWeb - Aug 22 2014]
Entities: HIV/AIDS, Drugs, Market
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Invitation to Webcast of Bionor Pharma Q2 2014 Results 15 August

) Bionor Pharma ASA (OSE:BIONOR) will announce its second quarter 2014 results 15 August 2014 at 7.00 CEST.The quarterly report and presentation will be available at the Company's website at this time www.bionorpharma.com.Presentation of first quarter ... [Published Noodls - Aug 14 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Celgene cancer drug reactivates latent HIV reservoirs

Bionor Pharma ASA (OSE:BIONOR) presented data at the International AIDS Society meeting that the company said show for the first time that cancer drug Istodax romidepsin can reactivate latent HIV reservoirs in HIV-infected patients. In six patients w ... [Published BioPortfolio - Jul 23 2014]

More Content

All (8) | News (7) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
REG-Mandatory Notification of Trade [Published Reuters - Sep 05 2014]
REG-BIONOR PHARMA ASA - CONTEMPLATED PRIVATE PL... [Published Reuters - Sep 04 2014]
Bionor Pharma Q2 net loss decreases [Published Individual.com - Aug 27 2014]
Bionor Pharma: Vacc-4X Remains On Track [Published Investing.com - Aug 26 2014]
Worldwide HIV Infection Drug Market Examined in... [Published PRWeb - Aug 22 2014]
Invitation to Webcast of Bionor Pharma Q2 2014 ... [Published Noodls - Aug 14 2014]
Celgene cancer drug reactivates latent HIV rese... [Published BioPortfolio - Jul 23 2014]
Bionor Pharma's Phase II Vacc-4x Data Published... [Published Marketwire - Breaking News Releases - Feb 11 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Bionor Pharma's Phase II Vacc-4x Data Published... [Published Marketwire - Breaking News Releases - Feb 11 2014]
Therapeutic HIV Vaccine, Vacc-4x, Reduced Viral Load in HIV Patients Compared to Placebo in Largest Randomized, Placebo-Controlled Study of Its Kind in Recent History, Published in Lancet Infectious Diseases ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.